Halozyme Therapeutics Inc

Open

SectorGezondheidszorg

75.17 3.64

Overzicht

Wijziging aandelenprijs

24u

Huidig

Min

71.97

Max

75.27

Belangrijke statistieken

By Trading Economics

Inkomsten

292M

150M

Verkoop

-75M

377M

K/W

Sectorgemiddelde

24.207

50.958

EPS

1.221

Winstmarge

39.832

Werknemers

423

EBITDA

-62M

220M

Aanbevelingen

By TipRanks

Aanbevelingen

Buy

12 Maanden Prognose

+13.84% upside

Dividenden

By Acuity

Volgende Winsten

4 aug 2026

Marktinformatie

By TradingEconomics

Marktkapitalisatie

533M

8.2B

Vorige openingsprijs

71.53

Vorige sluitingsprijs

75.17

Nieuwssentiment

By Acuity

50%

50%

141 / 342 Rangschikking in Healthcare

Halozyme Therapeutics Inc Grafiek

Eerdere prestaties zijn geen betrouwbare indicator voor toekomstige resultaten.

Gerelateerd nieuws

25 jun 2026, 23:51 UTC

News

Crude oil prices rise amid escalating Middle East tensions after a projectile strike near Oman. The United States Oil Fund LP is slightly higher after hours.

25 jun 2026, 23:51 UTC

Social Media
Correlated Moves
News

Qualcomm is in talks to acquire Modular for $4 billion. Shares are trading lower after the company's optimistic revenue targets and Investor Day updates.

25 jun 2026, 23:51 UTC

Social Media
News

Micron Technology Inc. shares fell in after-market trading despite a 350% year-over-year revenue increase, amid broader tech sector weakness.

25 jun 2026, 23:42 UTC

News
Macro News
ETF Constituents

The Vanguard Information Technology ETF rose in after-market trading, boosted by Micron's strong earnings and revenue forecast, despite mixed broader market sentiment.

25 jun 2026, 23:41 UTC

ETF Constituents
Social Media
News
Correlated Moves

SPDR S&P 500 ETF Trust trades higher after market close, supported by positive returns from top holdings like Microsoft and Apple amid mixed market sentiment.

25 jun 2026, 23:41 UTC

News
ETF Constituents
Social Media

Invesco QQQ Trust Series I rises in after-market hours, supported by a gain in the Nasdaq 100. Microsoft, Apple, and Meta contributed positively to performance.

25 jun 2026, 23:41 UTC

News
Social Media

Apple Inc. has raised prices for its MacBook and iPad models due to higher memory and storage costs. Shares are advancing in after-market trading.

25 jun 2026, 23:41 UTC

Social Media
News

Microsoft shares are higher in after-market trading following Thursday's close. Analysts are cautious amid rising console storage costs and AI spending concerns.

25 jun 2026, 23:26 UTC

News
ETF Constituents
Social Media

Vanguard Growth ETF shares advanced in after-market trading, supported by gains from Microsoft, Apple, and Meta, following four sessions of declines.

25 jun 2026, 23:22 UTC

News

Tesla's energy division may drive growth amid EV market challenges. Shares traded roughly flat during after-market hours following Thursday's close.

25 jun 2026, 23:06 UTC

ETF Constituents
News

The SPDR Dow Jones Industrial Average ETF Trust is higher in after-market trading, supported by positive economic data and contributions from Microsoft and Goldman Sachs.

25 jun 2026, 20:07 UTC

News
Macro Event
Correlated Moves

The USD/SEK exchange rate is lower today, influenced by upward revisions in US GDP growth and personal spending figures.

25 jun 2026, 20:07 UTC

News

Starbucks shares are lower despite reports of U.S. sales growth and upgraded earnings guidance. The stock pulled back from earlier session highs amid broader market dynamics.

25 jun 2026, 20:07 UTC

Macro Event
News

Positive U.S. macroeconomic indicators lift USD/NOK, which is trading higher since Wednesday's close and remains near the upper end of its one-month range.

25 jun 2026, 20:07 UTC

Macro Event
News

The USD/CZK exchange rate remains roughly flat, influenced by recent U.S. economic reports, including an upward revision of Q1 GDP growth to 2.1%.

25 jun 2026, 20:07 UTC

Correlated Moves
News
Macro Event

The USD/PLN is trading lower today, influenced by recent U.S. economic data and a slight decline in the US Dollar Index.

25 jun 2026, 20:07 UTC

News
Macro Event
Correlated Moves

The USD/HUF exchange rate is lower today, reflecting a slight decline since Wednesday. U.S. macroeconomic data contributed to recent volatility in the currency pair.

25 jun 2026, 20:07 UTC

Correlated Moves
Macro Event
News

The USD/DKK exchange rate is declining, influenced by upward revisions in US GDP growth and muted responses to personal income and spending data.

25 jun 2026, 20:07 UTC

News
Correlated Moves

The GBP/HKD exchange rate is rising, supported by an increase in GBP/USD amid ongoing inflation concerns and geopolitical tensions in the Strait of Hormuz.

25 jun 2026, 20:07 UTC

News
Correlated Moves

Ethereum is lower today, influenced by Bitcoin's decline. It remains below its 20-day moving average and has finished lower for three consecutive sessions.

25 jun 2026, 20:07 UTC

Correlated Moves
Macro Event
News

Bitcoin is lower today, impacted by the expiration of $10 billion in options and geopolitical tensions. Ethereum also declines, reflecting similar market conditions.

25 jun 2026, 20:07 UTC

Macro Event
News
Correlated Moves

Bitcoin is lower today, driven by the expiration of $10 billion in options and geopolitical tensions following an attack in the Strait of Hormuz.

25 jun 2026, 20:06 UTC

News

The Nikkei 225 Index is higher in after-market hours, supported by earlier gains and remaining above its 20-day moving average. No specific news was identified.

25 jun 2026, 19:56 UTC

ETF Constituents
News
Correlated Moves

Vanguard Real Estate ETF is higher as Simon Property Group and Welltower contribute positively, despite uncertainty from the postponed housing affordability bill.

25 jun 2026, 19:56 UTC

News
Macro Event
Social Media

Geopolitical tensions from an attack on a cargo ship have pressured U.S. Treasury yields, contributing to a decline in the iShares 20+ Year Treasury Bond ETF.

25 jun 2026, 19:46 UTC

Correlated Moves
News

Ethereum is trading lower amid persistent inflation and geopolitical tensions affecting oil supply. The asset remains below its 20-day moving average.

25 jun 2026, 19:26 UTC

News

Sirius XM Holdings Inc. is lower amid mixed US market performance and declines in major tech stocks, reflecting profit-taking and valuation concerns.

25 jun 2026, 19:16 UTC

Correlated Moves
News

The U.S. core PCE price index rose in May, suggesting ongoing inflation. The Vanguard Mortgage-Backed Securities ETF is trading higher since Wednesday's close.

25 jun 2026, 19:16 UTC

Macro Event
Correlated Moves
News

The Vanguard Total Bond Market ETF is higher today, supported by rising inflation data and an upward revision in Q1 GDP growth, reflecting stronger economic activity.

24 jun 2026, 23:56 UTC

News
Correlated Moves

Ethereum is trading lower during Wednesday's session, reflecting broader market trends as Bitcoin also declines. The cryptocurrency remains below its 20-day moving average.

Peer Vergelijking

Prijswijziging

Halozyme Therapeutics Inc Prognose

Koersdoel

By TipRanks

13.84% opwaarts potentieel

12 Maanden Prognose

Gemiddelde 81 USD  13.84%

Hoogste 96 USD

Laagste 57 USD

Gebaseerd op 6 Wall Street-analisten die 12-maands prijsdoelen bieden voor Halozyme Therapeutics Inc - Dist. in de afgelopen 3 maanden.

Beoordelingsconsensus

By TipRanks

Buy

6 ratings

3

Buy

2

Hold

1

Sell

Sentiment

By Acuity

141 / 342 Rangschikking in Gezondheidszorg

Nieuwssentiment

Neutral

Volatiliteit

Onder gemiddelde

Nieuws Volume (RCV)

Onder gemiddelde

Financieel

Verkoop- en administratiekosten

Bedrijfskosten

Winst voor belastingen

Verkoop

Kosten van verkopen

Brutowinst op verkopen

Rente-uitgaven op schulden

EBITDA

Operationele winst

$

Over Halozyme Therapeutics Inc

Halozyme Therapeutics, Inc., a biopharma technology platform company, researches, develops, and commercializes proprietary enzymes and devices in the United States, Switzerland, Belgium, Japan, and internationally. The company's products are based on the patented recombinant human hyaluronidase enzyme (rHuPH20) that enables delivery of injectable biologics, such as monoclonal antibodies and other therapeutic molecules, as well as small molecules and fluids. It offers Hylenex recombinant, a formulation of rHuPH20 to facilitate subcutaneous (SC) fluid administration for achieving hydration to enhance the dispersion and absorption of other injected drugs in SC urography and to enhance resorption of radiopaque agents; rilpivirine, cabotegravir, and N6LS BNAB for the treatment of HIV; ocrelizumab for multiple sclerosis; XYOSTED, an injection for SC administration of testosterone replacement therapy; and ATRS-1902, a proprietary drug device combination product. The company also provides Herceptin (trastuzumab), Herceptin Hylecta, and Phesgo to treat breast cancer; Mabthera SC for the treatment of chronic lymphocytic leukemia; HYQVIA to treat primary immunodeficiency disorders; and DARZALEX for patients with amyloidosis, smoldering myeloma, and multiple myeloma. In addition, it offers Epinephrine Injection to treat allergic reactions; nivolumab+relatlimab and ANTI-TIM3 for the treatment of solid tumors; ARGX-117 for multifocal motor neuropathy; atezolizumab; nivolumab; afgartigimod; teriparatide injections; and OTREXUP, a SC methotrexate injection for adults with severe active rheumatoid arthritis and severe recalcitrant psoriasis, as well as children with active polyarticular juvenile idiopathic arthritis. Further, the company provides ATRS-1902 for adrenal crisis rescue; ARGX-113; and ARGX-117 to treat severe autoimmune diseases in multifocal motor neuropathy. Halozyme Therapeutics, Inc. was founded in 1998 and is headquartered in San Diego, California.
help-icon Live chat